Brazil plays a central role in the global food economy. It leads the world in exports of soybeans, beef, sugar, coffee, and orange juice, and is among the top producers of corn, cotton, and ethanol. Its mix of scale, land availability, and growing technological...
Regulatory
Patent eligibility across Latin American countries
Discover the intricacies of patent eligibility across Latin America with our expert guide. This comprehensive report delves into the legal frameworks and regulations that govern the patentability of cutting-edge innovations in Life Sciences, including biotechnology,...
A granted patent has any influence in determining the price of a medication by the Government?
Explore the complexities of drug pricing regulations across Latin America with our in-depth analysis. This comprehensive guide provides valuable insights into how patent status influences medication pricing in key markets like Brazil, Argentina, Chile, and more....
Brazilian patent applications covering technologies for cancer treatment can be granted in 1 year
The number of cancer cases in Brazil and in the world is increasing each year, which generates a national and global concern to improve the effectiveness in the treatment and prevention of new cases.Fill the form and download our material.
Protection and registration of plant varieties in Brazil
Despite being eligible for patent protection in some countries (such as, the United States, Europe and Japan), plants, even if transgenic, are excluded from patentable subject matter in Brazil according to the provisions of Articles 10 (IX) and 18 (III) of Brazilian...
Brazilian pto publishes the final version of the guidelines for examining inventions related to transgenic plants
Brazilian pto publishes the final version of the guidelines for examining inventions related to transgenic plants, especially elite events.Fill the form and download our material.
Brazil’s ANVISA approves new regulation for biosimilar drug registration simplifying the development process for biosimilars
On May 27, ANVISA (Brazilian Health Regulatory Agency) approved a new regulation for the registration of biosimilar drugs, aiming to simplify and expedite their development.Fill the form and download our material.
YEAR IN REVIEW: PHARMACEUTICAL PRODUCTS
The Executive Group of the Economic-Industrial Health Complex (GECEIS) is was established by Decree…
YEAR IN REVIEW: AGRIBUSINESS
The Supreme Court ruled constitutional some of the main provisions of Decree 10833/2021 that modified Decree 4074/2002, such as those establishing…
YEAR IN REVIEW: MEDICAL DEVICES
ANVISA allows the importation of medical devices, including their accessories, with manufacturing dates preceding the dates of notification or registration publication, provided that the time lapse does not exceed 5 (five) years, and that…
NAVIGATING THE BRAZILIAN REGULATORY SYSTEM FOR LIFE SCIENCES & AGRIBUSINESS
The area of Regulatory Law in Life Sciences & Agribusiness plays an essential role in balancing scientific innovation and the protection of public…
Life Sciences & Agribusiness
The Supreme Court ruled constitutional some of the main provisions of Decree 10833/2021 that modified Decree 4074/2002, such as those establishing deadlines for the government authorities to analyze pesticides registration requests…
ANVISA approves regulatory impact analysis report on cannabis products for medical purposes
It is not news that cannabis-based products have been used for millennia around the world in the treatment…
The main obstacles to obtain patent protection for car-t cell-related technologies in Brazil
As research and development efforts move forward in relation to CAR-T…
Unveiling Opportunities in Brazilian Agribusiness
In the vast Brazilian territory, one sector stands out as the fundamental pillar of its economy and a true engine of growth: agribusiness. With fertile lands, favorable climate, and a robust agricultural heritage, Brazil solidifies…